MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies

LOS ANGELES, Feb. 26, 2024 /PRNewswire/ — Today MAX BioPharma, Inc. ( and Metaba, LLC ( announced their collaboration in studying the effects of oxysterol drug candidates that target non-alcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks